Meta tags:
description= We are an innovative global healthcare company with one purpose: to chase the miracles of science to improve people’s lives.;
keywords= healthcare pharmaceutical product drug development medicines vaccines artificial intelligence immunology neurology oncology rare blood disorders diseases ardiovascular diabetes influenza meningococcal meningitis pertussis respiratory syncytial virus;
Headings (most frequently used words):
our, the, 2024, equity, explore, sanofi, disease, rare, action, in, day, report, sleeping, sickness, into, leaving, no, one, behind, nojargon, dive, work, world, of, science, cancer, corp, acting, together, diversity, and, inclusion, legacy, integrated, journey, vs, paris, meningitis, flag, women, at, cristina, 200, days, to, go, until, paralympic, games, today, latest, news, more, career, opportunities, virus, bacteria, consumer, healthcare, 2022,
Text of the page (most frequently used words):
the (41), and (31), our (22), 2024 (15), sanofi (13), #read (12), #healthcare (10), #disease (10), #press (9), #rare (9), #more (9), #results (8), for (7), release (7), #your (7), financial (7), february (7), with (6), scientific (6), equity (6), clinical (5), collaboration (5), #report (5), partnering (5), #health (5), vaccines (5), diversity (5), see (5), flag (5), discover (5), meningitis (5), consumer (5), access (5), publications (4), company (4), social (4), governance (4), america (4), support (4), people (4), global (4), media (4), today (4), areas (4), treatment (4), team (4), paris (4), focus (4), all (3), inclusion (3), adrs (3), sickness (3), sleeping (3), day (3), science (3), oncology (3), world (3), investor (3), medicines (3), article (3), shares (3), immunology (3), impact (3), beyond (3), diseases (3), latest (3), trials (3), one (3), virus (3), innovation (3), that (3), you (3), north (3), business (3), reports (3), into (3), partnership (2), are (2), platforms (2), bacteria (2), adults (2), para (2), athletes (2), digital (2), code (2), reduced (2), china (2), paralympic (2), meet (2), cristina (2), trial (2), update (2), technology (2), conduct (2), investors (2), careers (2), esg (2), quarterly (2), corp (2), environment (2), conditions (2), part (2), action (2), news (2), annual (2), contacts (2), variant (2), general (2), scientists (2), but (2), patients (2), events (2), full (2), neurology (2), rights (2), possible (2), dupixent (2), sustainability (2), workplace (2), blood (2), potential (2), strategy (2), new (2), disorders (2), center (2), impossible (2), leadership (2), wellness (2), contact (2), this (2), legacy (2), document (2), explore (2), professionals (2), releases (2), career (2), first (2), data (2), inflammation (2), honor, shine, light, largely, preventable, better, importance, artificial, impulsions, relays, study, torches, olympic, find, intelligence, environmental, living, pipeline, diagnosis, killers, pursuit, responsible, yet, morana, infectious, empower, women, leaders, female, generation, next, helping, inspired, inspiring, many, committee, lead, board, directors, created, executive, largest, vulnerable, remains, resilience, understanding, increase, seeks, cup, communities, ellie, davide, curin, specialist, committees, théo, challis, studies, maps, volunteers, cold, broker, conferences, meetings, cardiovascular, presentations, diabetes, magazine, development, reserved, allergy, flu, out, licensing, neuroscience, assessment, cough, digestive, care, pain, post, mental, physical, patient, pta, pre, registration, import, licenses, managed, why, materiality, sponsored, vara, investigator, terms, well, reporting, key, shareholder, regulated, programs, information, share, repurchases, voting, europe, consensus, double, shareholding, structure, influenza, dividend, meningococcal, stock, chart, individual, shareholders, pertussis, syncytial, respiratory, production, matter, project, operations, policy, containing, universel, enregistrement, privacy, french, form, cookies, 2023, filing, type, protection, copd, review, continues, late, fda, demonstrate, activity, improved, significantly, severity, itch, rapidly, rilzabrutinib, phase, breaking, asthma, severe, moderate, uncontrolled, plugging, mucus, airway, showing, priority, legal, spontaneous, improve, portal, built, story, 2022, integrated, everywhere, lives, making, turning, how, surprised, what, opportunities, here, future, can, heritage, year, accepted, towards, sbla, notice, back, top, achieving, unleashing, reflecting, made, culture, progress, tangible, celebrates, stage, took, follow, chronic, urticaria, zamora, they, main, explain, them, know, really, achieve, life, journey, between, good, force, transforming, community, means, latin, hispanic, italy, differences, compliance, unite, games, until, days, 200, against, fight, accessibility, flying, will, partial, country, their, fly, gearing, germany, 2004, cancer, infected, without, fatal, usually, tropical, neglected, articles, directory, dive, nojargon, sitemap, together, acting, work, acute, rhodesiense, certified, goal, becoming, behind, leaving, 2030, humans, elimination, supporting, have, oral, these, horizon, hope, options, little, seen, sadly, pharmaceutical,
Text of the page (random words):
sanofi global healthcare and pharmaceutical company our company our company our strategy governance governance board of directors executive committee specialist committees social impact social impact access to healthcare innovation for vulnerable communities environmental sustainability and resilience diversity equity and inclusion in and beyond the workplace code of conduct and responsible business our legacy our science our science our pipeline r d focus areas r d focus areas immunology r d neurology r d oncology r d rare blood disorders r d rare diseases r d vaccines r d artificial intelligence in r d technology platforms clinical trials results clinical trials results find a clinical trial clinical study results investigator sponsored studies diversity in clinical trials scientific collaboration scientific collaboration scientific collaboration in north america scientific collaboration in europe scientific collaboration in china digital your health your health vaccines vaccines influenza meningococcal meningitis pertussis respiratory syncytial virus production why vaccines matter medicines medicines immunology neurology oncology rare blood disorders rare diseases cardiovascular diseases diabetes consumer healthcare consumer healthcare sustainability at sanofi consumer healthcare allergy cough cold flu digestive wellness pain care physical mental wellness patient support healthcare professionals support healthcare professionals support managed access programs maps pre registration import licenses post trial access pta partnering partnering partnering focus areas partnering focus areas china digital general medicines immunology neuroscience oncology out licensing rare disease technology platforms vaccines meet the partnering team contact business development team media media press releases media contacts magazine sanofi today investors investors financial results and investor events financial results and investor events quarterly results investor presentations annual general meetings broker conferences environment social governance environment social governance our double materiality assessment our latest esg news esg quarterly update individual shareholders shares and adrs shares and adrs sanofi stock chart dividend adrs shareholding structure vara consensus shares voting rights share repurchases financial reports and publications financial reports and publications financial reports and regulated information shareholder publications financial reporting center and key data contacts careers careers all well global terms and conditions paris 2024 partnership paris 2024 partnership team sanofi volunteers sanofi cup impulsions 2024 paris 2024 olympic and paralympic torches relays global rare disease day 2024 equity in action in honor of rare disease day we shine a light on the importance of equity in the pursuit of better diagnosis innovation support and access for people living with rare conditions discover more the meningitis flag co created and inspired by team sanofi para athletes ellie challis théo curin and davide morana the meningitis flag seeks to increase the understanding of a disease that remains one of the world s largest infectious disease killers and yet is largely preventable discover more women at sanofi cristina meet cristina zamora our north america r d operations project lead and one of the many inspiring scientists that are helping to empower the next generation of female leaders in healthcare and beyond see more 200 days to go until the paris 2024 paralympic games as para athletes are gearing up to fly their country s flag a new flag will be flying the meningitis flag to unite the world in the fight against meningitis discover more virus vs bacteria they re part of your life but do you really know them our scientists explain the main differences between a virus and a bacteria read more our consumer healthcare s b corp journey becoming b corp certified in sanofi consumer healthcare north america germany italy and hispanic latin america means we re part of a global community that s transforming business into a force for good see more sleeping sickness leaving no one behind a neglected tropical disease sleeping sickness is usually fatal without treatment patients infected with the more acute t b rhodesiense variant of the disease have sadly seen little innovation in treatment options but hope is on the horizon for these patients we see the potential of the first oral treatment for this variant of the disease supporting the goal of elimination of sleeping sickness in humans by 2030 see more sanofi today read our latest articles your health february 27 2024 rare disease day 2024 equity in action read the article your health february 7 2024 nojargon dive into the world of science read the article your health february 5 2024 cancer work acting together read the article our latest news february 24 2024 press release phase 2 results demonstrate rilzabrutinib rapidly reduced itch severity and significantly improved disease activity in adults with chronic spontaneous urticaria read the press release february 24 2024 media update dupixent continues scientific leadership with late breaking results showing reduced airway inflammation and mucus plugging in adults with uncontrolled moderate to severe asthma read the press release february 23 2024 press release filing of the 2023 u s form 20 f and french document d enregistrement universel containing the annual financial report read the press release february 23 2024 press release dupixent sbla accepted for fda priority review for treatment of copd with type 2 inflammation read the press release see all press releases explore more diversity equity and inclusion report in the first full year of our new people and culture strategy diversity equity and inclusion took center stage this report celebrates the tangible progress we ve made towards reflecting diversity in our leadership unleashing the full potential of our people and achieving impact in and beyond the workplace read the document our legacy our company of today is built on a heritage of turning the impossible into the possible read our story our integrated report 2022 discover how we re making the impossible possible to improve people s lives everywhere read the report explore career opportunities you ll be surprised what you can achieve at sanofi discover your future here access career portal follow us back to top contact legal notice privacy data protection cookies policy sanofi today our publications sitemap directory accessibility partial compliance code of conduct sanofi 2004 2024 all rights reserved
|